| Secondary |
| Product Used For Unknown Indication |
42.8% |
| Epilepsy |
13.2% |
| Drug Use For Unknown Indication |
11.8% |
| Convulsion |
10.5% |
| Lennox--gastaut Syndrome |
7.2% |
| Pain |
3.9% |
| Liver Transplant |
2.0% |
| Partial Seizures |
1.3% |
| Relapsing-remitting Multiple Sclerosis |
1.3% |
| Depression |
0.7% |
| Grand Mal Convulsion |
0.7% |
| Ill-defined Disorder |
0.7% |
| Juvenile Myoclonic Epilepsy |
0.7% |
| Kidney Infection |
0.7% |
| Memory Impairment |
0.7% |
| Mucopolysaccharidosis Ii |
0.7% |
| Sleep Disorder |
0.7% |
| Systemic Lupus Erythematosus |
0.7% |
|
| Drug Exposure During Pregnancy |
12.1% |
| Vomiting |
12.1% |
| Toxicity To Various Agents |
9.1% |
| Accidental Poisoning |
6.1% |
| Death |
6.1% |
| Malaise |
6.1% |
| Respiratory Arrest |
6.1% |
| Sudden Unexplained Death In Epilepsy |
6.1% |
| Communication Disorder |
3.0% |
| Completed Suicide |
3.0% |
| Drug Abuse |
3.0% |
| Drug Ineffective |
3.0% |
| Negative Thoughts |
3.0% |
| Nervous System Disorder |
3.0% |
| Nightmare |
3.0% |
| Oropharyngeal Pain |
3.0% |
| Periodontitis |
3.0% |
| Rash |
3.0% |
| Status Epilepticus |
3.0% |
| Tachycardia |
3.0% |
|
| Concomitant |
| Epilepsy |
27.9% |
| Product Used For Unknown Indication |
21.8% |
| Convulsion |
8.6% |
| Drug Use For Unknown Indication |
5.8% |
| Status Epilepticus |
4.6% |
| Smoking Cessation Therapy |
4.0% |
| Intestinal Obstruction |
3.7% |
| Osteoporosis |
2.8% |
| Pain |
2.5% |
| Ischaemia |
2.1% |
| Multiple Sclerosis |
2.1% |
| B Precursor Type Acute Leukaemia |
1.8% |
| Gaucher's Disease |
1.8% |
| Testis Cancer |
1.8% |
| Grand Mal Convulsion |
1.5% |
| Niemann-pick Disease |
1.5% |
| Partial Seizures |
1.5% |
| Schizophrenia |
1.5% |
| Depression |
1.2% |
| Diabetes Mellitus |
1.2% |
|
| Epilepsy |
14.8% |
| Convulsion |
13.0% |
| Small For Dates Baby |
9.3% |
| Vomiting |
6.5% |
| Drug Ineffective |
5.6% |
| Weight Decreased |
5.6% |
| Nausea |
4.6% |
| Somnolence |
4.6% |
| Loss Of Consciousness |
3.7% |
| Weight Increased |
3.7% |
| Withdrawal Syndrome |
3.7% |
| Death |
2.8% |
| Diarrhoea |
2.8% |
| Drug Exposure During Pregnancy |
2.8% |
| Drug Ineffective For Unapproved Indication |
2.8% |
| Fall |
2.8% |
| Gait Disturbance |
2.8% |
| Hypoproteinaemia |
2.8% |
| Hypotension |
2.8% |
| Multiple Sclerosis Relapse |
2.8% |
|
| Interacting |
| Breast Cancer |
50.0% |
| Schizophrenia |
50.0% |
|
| Drug Interaction |
50.0% |
| Drug Level Decreased |
25.0% |
| Musculoskeletal Pain |
25.0% |
|
